Literature DB >> 23900429

[Predictive marker for acute normal tissue toxity in radiotherapy of non-small cell lung cancer].

E Dikomey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23900429     DOI： 10.1007/s00066-013-0399-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  8 in total

1.  No effect of the transforming growth factor β1 promoter polymorphism C-509T on TGFB1 gene expression, protein secretion, or cellular radiosensitivity.

Authors:  Sebastian Reuther; Elisabeth Metzke; Michael Bonin; Cordula Petersen; Ekkehard Dikomey; Annette Raabe
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-15       Impact factor: 7.038

2.  A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer.

Authors:  Xiaomin Niu; Hongxuan Li; Zhiwei Chen; Yun Liu; Mengyuan Kan; Daizhan Zhou; Ziming Li; Xiangyun Ye; Shengping Shen; Changxing Lv; Shun Lu
Journal:  J Thorac Oncol       Date:  2012-11       Impact factor: 15.609

3.  Association between single nucleotide polymorphisms of the transforming growth factor β1 gene and the risk of severe radiation esophagitis in patients with lung cancer.

Authors:  Jose Luis Lopez Guerra; Daniel Gomez; Qingyi Wei; Zhengshen Liu; Li-E Wang; Xianglin Yuan; Yan Zhuang; Ritusko Komaki; Zhongxing Liao
Journal:  Radiother Oncol       Date:  2012-09-27       Impact factor: 6.280

4.  Association of TGF-β1 and XPD polymorphisms with severe acute radiation-induced esophageal toxicity in locally advanced lung cancer patients treated with radiotherapy.

Authors:  Li Zhang; Ming Yang; Nan Bi; Wei Ji; Chen Wu; Wen Tan; Lujun Zhao; Dianke Yu; Dongxin Lin; Luhua Wang
Journal:  Radiother Oncol       Date:  2010-10       Impact factor: 6.280

5.  Genetic control of the circulating concentration of transforming growth factor type beta1.

Authors:  D J Grainger; K Heathcote; M Chiano; H Snieder; P R Kemp; J C Metcalfe; N D Carter; T D Spector
Journal:  Hum Mol Genet       Date:  1999-01       Impact factor: 6.150

6.  Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.

Authors:  Xianglin Yuan; Zhongxing Liao; Zhensheng Liu; Li-E Wang; Susan L Tucker; Li Mao; Xin Shelley Wang; Mary Martel; Ritsuko Komaki; James D Cox; Luka Milas; Qingyi Wei
Journal:  J Clin Oncol       Date:  2009-04-20       Impact factor: 44.544

7.  Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.

Authors:  Hekun Jin; Susan L Tucker; Hui Helen Liu; Xiong Wei; Sue Sun Yom; Shulian Wang; Ritsuko Komaki; Yuhchyau Chen; Mary K Martel; Radhe Mohan; James D Cox; Zhongxing Liao
Journal:  Radiother Oncol       Date:  2008-10-18       Impact factor: 6.280

8.  Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy.

Authors:  Annette Raabe; Katharina Derda; Sebastian Reuther; Silke Szymczak; Kerstin Borgmann; Ulrike Hoeller; Andreas Ziegler; Cordula Petersen; Ekkehard Dikomey
Journal:  Radiat Oncol       Date:  2012-04-26       Impact factor: 3.481
  8 in total
  2 in total

1.  Association between SNPs in defined functional pathways and risk of early or late toxicity as well as individual radiosensitivity.

Authors:  Sebastian Reuther; Silke Szymczak; Annette Raabe; Kerstin Borgmann; Andreas Ziegler; Cordula Petersen; Ekkehard Dikomey; Ulrike Hoeller
Journal:  Strahlenther Onkol       Date:  2014-08-26       Impact factor: 3.621

2.  Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).

Authors:  Franz Zehentmayr; Matthias Söhn; Ann-Katrin Exeli; Karl Wurstbauer; Almut Tröller; Heinz Deutschmann; Gerd Fastner; Christoph Fussl; Philipp Steininger; Manfred Kranzinger; Claus Belka; Michael Studnicka; Felix Sedlmayer
Journal:  Radiat Oncol       Date:  2015-05-28       Impact factor: 3.481
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.